[REPORT] How will Post-COVID evolve life sciences?

How will Post-COVID evolve life sciences?
1,365 industry professionals were asked their opinion on COVID’s impact and what this all means for life sciences in the coming months and years.

This research was performed by Omnipresence, in collaboration with Reuters Events Pharma, and contains insights from life sciences professionals on multiple topics, including:

  • Commercial’s ability to deliver virtual engagement
  • Gaps in the most commonly used CRMs as well as in data analytics capabilities
  • The rise of Medical Affairs and the need to rethink its engagement with HCPs
  • Impact on R&D and the need to obtain RWE in new ways
  • Shifting payer priorities in light of pandemic

Learn what your peers believe will be the future of pharma, and see where you fit in.

Access the Pharma Post-COVID Report by Reuters Events Pharma.

Kind regards,

Lucy Muñiz
The Pharmaceutical Marketing Group